ArticleCureus2026
Bhutan's Response Against Increasing Number of Stroke (BRAINS): A Hybrid Type II Effectiveness-Implementation Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Bhutan faces a growing stroke burden as the third leading cause of death, compounded by delayed hospital arrivals, fragmented care, and near-absent thrombolysis due to systemic gaps in protocols and trained workforce. Methods This hybrid type II implementation study (2020-2023) employed the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework to evaluate a physician-led stroke care model across Bhutan's referral hospitals. Interventions included capacity-building for non-neurologists, protocol standardization, and stroke unit (SU) establishment. We used an uncontrolled pre-post design, comparing six months of retrospective baseline data (January 2020 to June 2020) to prospective post-intervention data (October 2022 to March 2023). Results The introduction of a physician-led stroke care model in Bhutan's national referral hospitals led to measurable gains across all RE‑AIM domains. Adherence to stroke care quality indicators nearly doubled (30%-57%), and unadjusted in-hospital mortality decreased substantially from 29% to 9% post‑intervention (adjusted odds ratio {aOR}, 0.65; 95% CI, 0.50-0.85). However, the causal interpretation of the mortality reduction is limited by the lack of adjustment for baseline stroke severity. The sustainability of the intervention faced challenges from high staff attrition (55%), affecting protocol fidelity. This highlighted the need for systemic workforce retention strategies and sustained leadership to ensure long-term maintenance. Conclusion The findings of the Bhutan's Response Against Increasing Number of Stroke (BRAINS) initiative suggest that key elements of organized stroke care may be successfully adapted to low-resource settings. The outcomes in Bhutan, consistent with experiences in India and South Africa, suggest that models built around dedicated units, trained teams, and standard protocols hold promise for replication. The long-term sustainability of such improvements, however, seems to rely on addressing systemic constraints. The initiative implies that challenges such as workforce retention and limited specialist availability may be addressed by strategies such as training non-neurologist physicians and establishing clear career pathways for nursing staff. Taken together, the initiative's experience supports the inference that with local tailoring, a structured and team-based approach to stroke care could be a viable model for similar low-middle-income country (LMIC) contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.